- CA$24.95m
- CA$72.10m
- CA$78.60m
- 47
- 79
- 64
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.89 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.29 | ||
| EV to EBITDA | 289.57 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -23.61% | ||
| Return on Equity | -49.26% | ||
| Operating Margin | -15.22% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 17.31 | 19.44 | 47.79 | 78.6 | 84.14 | 91.36 | 65.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- April 1st, 2021
- Public Since
- July 4th, 2019
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
TSX Venture Exchange- Shares in Issue
- 79,219,171
- Address
- 199 Bay Street #4000, Toronto, M5L 1A9
- Web
- https://www.thinkresearch.com/ca/
- Phone
- +1 6479875083
- Contact
- Mark Sakamoto
- Auditors
- Ernst & Young LLP
Upcoming Events for THNK
Q1 2024 Think Research Corporation Earnings Release
Think Research Corporation Annual Shareholders Meeting
Q2 2024 Think Research Corporation Earnings Release
Similar to THNK
01 Communique Laboratory
TSX Venture Exchange
Acceleware
TSX Venture Exchange
Ackroo
TSX Venture Exchange
Adrabbit
TSX Venture Exchange
AGEDB Technology
TSX Venture Exchange
FAQ
What is the Think Research share price?
As of Today at 19:21 UTC, shares in Think Research are trading at CA$0.32. This share price information is delayed by 15 minutes.
How has the Think Research share price performed this year?
Shares in Think Research last closed at CA$0.32 and the price had moved by -25% over the past 365 days. In terms of relative price strength the Think Research share price has underperformed the Toronto Stock Exchange 300 Composite Index by -28.83% over the past year.
What are the analyst and broker recommendations for Think Research?
The overall consensus recommendation for Think Research is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Think Research dividend yield?
Think Research does not currently pay a dividend.
Does Think Research pay a dividend?
Think Research does not currently pay a dividend.
When does Think Research next pay dividends?
Think Research does not currently pay a dividend.
How do I buy Think Research shares?
To buy shares in Think Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Think Research?
As of the previous close price of CA$0.32, shares in Think Research had a market capitalisation of CA$24.95m.
Where are Think Research shares listed?
Here are the trading details for Think Research:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: THNK
What kind of share is Think Research?
Based on an overall assessment of its quality, value and momentum Think Research is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Think Research share price forecast for 2024?
The analyst consensus target price for shares in Think Research is CA$0.50. That is 58.73% above the last closing price of CA$0.32.
Analysts covering Think Research currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.18 for the next financial year.
Find out moreWhat is the trend in the Think Research share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Think Research. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -1.74%.
As of the last closing price of CA$0.32, shares in Think Research were trading +15.33% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Think Research PE Ratio?
The Think Research PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.32.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Think Research?
We do not have data on Think Research's directors